Lakefront Biotherapeutics (GLPGF) Gross Margin (QoQ) (2021 - 2026)
Powered by 
Analysis
Lakefront Biotherapeutics (GLPGF) Gross Margin (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 210.98 Bn | 196.99 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.24 Bn | 178.06 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.38 Bn | 124.53 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.97 Bn | 74.97 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.59 Bn | 56.41 Bn | 1.37 Bn |
| 6 | Moderna | 54.80 Bn | 49.67 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.09 Bn | 30.78 Bn | 992.69 Mn |
| 8 | Biogen | 31.34 Bn | 30.05 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.11 Bn | 30.11 Bn | 1.16 Mn |
| 10 | Lakefront Biotherapeutics | 1.73 Bn | 1.73 Bn | 3.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -105.00 |
| Mar 31, 2026 | 322,369.00 |
| Dec 31, 2025 | -328,244.00 |
| Sep 30, 2025 | -815.00 |
| Jun 30, 2025 | 1,116.00 |
| Mar 31, 2025 | -1,378.00 |
| Dec 31, 2024 | 597.00 |
| Sep 30, 2024 | -837.00 |
| Jun 30, 2024 | 195.00 |
| Mar 31, 2024 | -77.00 |
| Dec 31, 2023 | 607.00 |
| Sep 30, 2023 | -234.00 |
| Jun 30, 2023 | -95.00 |
| Mar 31, 2023 | -855.00 |
| Dec 31, 2022 | 424.00 |
| Sep 30, 2022 | 9.00 |
| Jun 30, 2022 | 26.00 |
| Mar 31, 2022 | -325.00 |
| Dec 31, 2021 | 133.00 |
| Sep 30, 2021 | -18.00 |